Latest News

 Filter by Provider

Construction materials company Vulcan Materials (NYSE:VMC) fell short of the market’s revenue expectations in Q4 CY2025 as sales rose 3.2% year on year to $1.91 billion. Its non-GAAP profit of $1.70 per share was 19.5% below analysts’ consensus estimates.

Nvidia will see monster growth in 2026 thanks to AI spending.

Bitcoin continues to struggle around $68,000, weighed down by persistent extreme fear sentiment and the absence of a clear catalyst for the next leg higher. Bitcoin ETFs saw $15.2 million in net inflows on Friday, while Ethereum ETFs reported $10.3 million in net inflows.

Elbit Systems (NASDAQ: ESLT) stock rose after securing $435 million in contracts for advanced defense systems.

Financial regulatory software provider Donnelley Financial Solutions (NYSE:DFIN) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 10.4% year on year to $172.5 million. On the other hand, next quarter’s revenue guidance of $205 million was less impressive, coming in 1.1% below analysts’ estimates. Its non-GAAP profit of $0.70 per share was 70.7% above analysts’ consensus estimates.

Krugman exposes how Trump's "destructive policy" and "corrupting influence" of big money blocks clean energy transition, risking U.S. growth.

Auto and industrial parts retailer Genuine Parts (NYSE:GPC) fell short of the market’s revenue expectations in Q4 CY2025 as sales rose 4.1% year on year to $6.01 billion. Its non-GAAP profit of $1.55 per share was 14.8% below analysts’ consensus estimates.

As the competitive landscape evolves, long-term Duolingo investors must look beyond user growth and ask more challenging strategic questions.

Teva stock rises after a new study, in partnership with Sanofi, shows lasting benefits in ulcerative colitis and Crohn's patients.

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 5.6% year on year to $3.52 billion. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $14.7 billion at the midpoint. Its non-GAAP profit of $4.07 per share was 3.2% above analysts’ consensus estimates.

Adobe Systems stock was a bearish candidate that came up on one of my screeners for being rated a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

The company announced an agreement to be acquired in an all-cash deal by a consortium led by Chairman and CEO William McMorrow and Fairfax Financial.

Bedding manufacturer Somnigroup (NYSE:SGI) fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 54.7% year on year to $1.87 billion. Its non-GAAP profit of $0.72 per share was in line with analysts’ consensus estimates.

Despite a steep decline over the past year, Solana could still triple in value in 2026.

Equipment rental company Herc Holdings (NYSE:HRI) fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 27.1% year on year to $1.21 billion. The company’s full-year revenue guidance of $4.34 billion at the midpoint came in 14.2% below analysts’ estimates. Its non-GAAP profit of $2.07 per share was 11% above analysts’ consensus estimates.

BHP Group signed a $4.3B silver streaming deal with Wheaton Precious Metals Corp for BHP's share of output from Antamina mine in Peru.

Eli Lilly's lung cancer trial shows lower recurrence risk and strong survival benefit in early-stage patients.

Analyst warns that the sell-off across crypto markets since early February may signal more than a short-term correction.

Southwest Airlines Co. (LUV) shares are trading higher during Tuesday's premarket session. Nasdaq futures are down 0.85% while S&P 500 futures have shed 0.38%.

Plan carefully to avoid a huge tax.

Chevron (CVX) expanding exploration portfolio in Mediterranean with 4 offshore block leases in Greece. Aligns with growth strategy.

The revised range suggests growth of roughly 27% to 33% above prior guidance, with the midpoint implying a whopping year-over-year surge of about 1,300%.

EU approves GSK's Exdensur for severe asthma and nasal polyps, offering twice-yearly dosing and fewer attacks in trials.

March S&P 500 E-Mini futures (ESH26) are down -0.40%, and March Nasdaq 100 E-Mini futures (NQH26) are down -0.85% this morning, pointing to a lower open on Wall Street after the long weekend as concerns around AI continue to weigh on sentiment.